Anti-high-density lipoprotein antibodies and lipoprotein characteristics in systemic lupus erythematosus-related cardiovascular disease

por Su, J, Cederholm, A, Hurt-Camejo, E, Svenungsson, E, Frostegård, J
Publicado 2005

Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: association with mortality

por Samal, S. K., Qureshi, A. R., Rahman, M., Stenvinkel, P., Frostegård, J.
Publicado 2020

Endothelial function and activation in women with systemic lupus erythematosus

por Svenungsson, E, Cederholm, A, Jensen-Urstad, K, Fei, G-Z, Frostegard, J
Publicado 2005

Non-traditional risk and protective factors for cardiovascular disease in systemic lupus erythematosus

por Cederholm, A, Svenungsson, E, Stengel, D, Fei, G-Z, Pockley, AG, Ninio, E, Frostegård, J
Publicado 2005

Immunoglobulin G1 Antibodies Against Phosphorylcholine Are Associated With Protection in Systemic Lupus Erythematosus and Atherosclerosis: Potential Underlying Mechanisms

por Thiagarajan, D., Fiskesund, R., Frostegård, A., Steen, J., Rahman, M., Vikström, M., Lundström, S., Frostegård, J.
Publicado 2020

Decreased binding of annexin V to endothelial cells: a novel mechanism of atherothrombosis in patients with systemic lupus erythematosus

por Cederholm, A, Svenungsson, E, Jensen-Urstad, K, Trollmo, C, Ulfgren, A-K, Swedenborg, J, Fei, G-Z, Frostegård, J
Publicado 2005

Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases

por de Vries, M. R., Ewing, M. M., de Jong, R. C. M., MacArthur, M. R., Karper, J. C., Peters, E. A. B., Nordzell, M., Karabina, S. A. P., Sexton, D., Dahlbom, I., Bergman, A., Mitchell, J. R., Frostegård, J., Kuiper, J., Ninio, E., Jukema, J. W., Pettersson, K., Quax, P. H. A.
Publicado 2021